Top Markets
#1 GENIUS AI GENIUS AI +165.14%
#2 Siren Siren +22.37%
#3 Janction Janction +15.38%
#4 ZetaChain ZetaChain +12.23%
#5 Resolv RLP Resolv RLP +11.52%
#6 WAX WAX +11.18%
#7 Cloud Cloud +9.02%
#8 SmarDex SmarDex +9.01%
#9 GXChain GXChain +8.98%
#10 Gunz Gunz +8.84%
Coin of the day
GENIUS AI GENIUS AI
Settings
Language
ENGLISH
Currency
USD
Theme
Gilead Sciences, Inc. Gilead Sciences, Inc.

Gilead Sciences, Inc.

GILD
Rank in Stocks #93
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and... Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of liver diseases. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of hematology, oncology, and cell therapy patients. In addition, the company provides Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; Ranexa, an oral formulation for the treatment of chronic angina; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Gadeta B.V.; Bristol-Myers Squibb Company; Dragonfly Therapeutics, Inc.; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California.
Share Price
$137.21
Market Cap
$170.34B
Change (1 day)
-2.76%
Change (1 year)
28.14%
Country
US
Trade Gilead Sciences, Inc. (GILD)

Category

Healthcare
Dividend yield history for Gilead Sciences, Inc. (GILD)
Gilead Sciences, Inc. (stock symbol: GILD) dividend yield (TTM) as of 2024-12-31: 3.40%
Average dividend yield, last 5 years : 3.43%
Dividend yield history for Gilead Sciences, Inc. (GILD) from 2000 to 2026
Dividend Yield at the end of each year (TTM)
Year Dividend Yield Change
2026 (TTM) 2.20% -14.40%
2025 2.57% -24.41%
2024 3.40% -9.81%
2023 3.77% 9.59%
2022 3.44% -12.91%
2021 3.95% -16.14%
2020 4.71% 20.77%
2019 3.90% 6.56%
2018 3.66% 25.34%
2017 2.92% 14.06%
2016 2.56% 101.57%
2015 1.27% 0.00%
2014 0.00% 0.00%
2013 0.00% 0.00%
2012 0.00% 0.00%
2011 0.00% 0.00%
2010 0.00% 0.00%
2009 0.00% 0.00%
2008 0.00% 0.00%
2007 0.00% 0.00%
2006 0.00% 0.00%
2005 0.00% 0.00%
2004 0.00% 0.00%
2003 0.00% 0.00%
2002 0.00% 0.00%
2001 0.00% 0.00%
2000 0.00% 0.00%
Dividend yields (TTM) for similar companies or competitors
Company Dividend Yield Country
Eli Lilly Eli Lilly
Eli Lilly
LLY.US
0.63%
US
AstraZeneca PLC AstraZeneca PLC
AstraZeneca PLC
AZN.US
1.64%
GB
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
2.15%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
3.03%
US
Novartis AG Novartis AG
Novartis AG
NVS.US
3.05%
CH